» Articles » PMID: 35997289

Interdisciplinary Intervention for the Management of Nonmedical Opioid Use Among Patients with Cancer Pain

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2022 Aug 23
PMID 35997289
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Few studies have assessed interventions aimed at managing nonmedical opioid use (NMOU) behavior among patients with cancer. The authors developed the Compassionate High-Alert Team (CHAT) intervention to manage patients receiving opioids for cancer pain who demonstrate NMOU behavior. The objective of this study was to determine the change in frequency of NMOU behaviors, pain intensity, and opioid requirements among those who received the intervention.

Methods: A total of 130 patients receiving opioids for cancer pain that had documented evidence of NMOU and received the CHAT intervention were reviewed. Demographic and clinical information such as NMOU behaviors, pain scores, and morphine equivalent daily dose at baseline, 3, and 6 months post-intervention was obtained.

Results: NMOU behaviors significantly decreased from a median (interquartile range) of 2 (1-3) at baseline to 0 (0-1) at both 3 and 6 months post-intervention (p < .001). A total of 45 of 75 (60%) and 31 of 50 (62%) of CHAT recipients achieved complete response to the intervention at 3 and 6 months, respectively. Higher baseline number of NMOU behaviors was independently associated with patient response to the intervention (odds ratio [OR], 1.97; 95% confidence interval [CI],1.09-4.28, p = .049 at 3 months; OR, 2.5; 95% CI, 1.20-6.47, p = .03 at 6 months). The median pain score decreased from 7 at baseline to 6 at both 3 and 6 months (p = .01). Morphine equivalent daily dose did not significantly change during that same period (143 mg/day vs. 139 mg/day, p = .13).

Conclusions: Most patients who received the CHAT intervention improved in their NMOU behaviors and pain intensity scores 3 and 6 months post-intervention. These preliminary findings support the efficacy of CHAT in managing patients receiving opioids for cancer pain who demonstrate NMOU behavior.

Citing Articles

Creating a Palliative Care Clinic for Patients with Cancer Pain and Substance Use Disorder.

Kale S, Tosto G, Rush L, Kullgren J, Russell D, Fried M J Pain Symptom Manage. 2024; 68(2):e138-e145.

PMID: 38670295 PMC: 11815907. DOI: 10.1016/j.jpainsymman.2024.04.011.


Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic cancer pain.

Arthur J, Edwards T, Lu Z, Amoateng M, Koom-Dadzie K, Zhu H Support Care Cancer. 2024; 32(2):121.

PMID: 38252311 DOI: 10.1007/s00520-024-08323-7.


Healthcare provider perceptions and reported practices regarding opioid prescription for patients with chronic pain.

Arthur J, Edwards T, Lu Z, Amoateng D, Koom-Dadzie K, Zhu H Res Sq. 2023; .

PMID: 37841840 PMC: 10571602. DOI: 10.21203/rs.3.rs-3367358/v1.

References
1.
Philip J, Smith W, Craft P, Lickiss N . Concurrent validity of the modified Edmonton Symptom Assessment System with the Rotterdam Symptom Checklist and the Brief Pain Inventory. Support Care Cancer. 1998; 6(6):539-41. DOI: 10.1007/s005200050212. View

2.
Arthur J, Tanco K, Haider A, Maligi C, Park M, Liu D . Assessing the prognostic features of a pain classification system in advanced cancer patients. Support Care Cancer. 2017; 25(9):2863-2869. DOI: 10.1007/s00520-017-3702-z. View

3.
Pergolizzi Jr J, Gharibo C, Passik S, Labhsetwar S, Taylor Jr R, Pergolizzi J . Dynamic risk factors in the misuse of opioid analgesics. J Psychosom Res. 2012; 72(6):443-51. DOI: 10.1016/j.jpsychores.2012.02.009. View

4.
Hui D, Shamieh O, Paiva C, Perez-Cruz P, Kwon J, Muckaden M . Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: A prospective, multicenter study. Cancer. 2015; 121(17):3027-35. PMC: 4595042. DOI: 10.1002/cncr.29437. View

5.
Arthur J, Tang M, Lu Z, Hui D, Nguyen K, Rodriguez E . Random urine drug testing among patients receiving opioid therapy for cancer pain. Cancer. 2020; 127(6):968-975. PMC: 10015495. DOI: 10.1002/cncr.33326. View